Aroa Biosurgery Limited (ASX:ARX)
Australia · Delayed Price · Currency is AUD 0.6000
-0.0200 (-3.23%)
May 18, 2026, 3:59 PM AEST
Aroa Biosurgery Market Cap
Aroa Biosurgery has a market cap or net worth of 207.54 million as of May 18, 2026. Its market cap has increased by 33.72% in one year.
Market Cap
207.54M
Enterprise Value
192.96M
Revenue
79.26M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.60
Market Cap Chart
Since July 24, 2020, Aroa Biosurgery's market cap has decreased from 405.10M to 207.54M, a decrease of -48.77%. That is a compound annual growth rate of -10.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 214.46M | -16.01% |
| Dec 31, 2025 | 255.32M | -3.86% |
| Dec 31, 2024 | 265.57M | -6.83% |
| Dec 29, 2023 | 285.06M | -23.02% |
| Dec 30, 2022 | 370.32M | 6.07% |
| Dec 31, 2021 | 349.14M | 0.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PolyNovo | 825.56M |
| Imricor Medical Systems | 651.99M |
| EBR Systems | 254.56M |
| EMVision Medical Devices | 162.18M |
| SomnoMed | 124.88M |
| Saluda Medical | 120.97M |
| Lumos Diagnostics Holdings | 115.48M |
| Cleo Diagnostics | 94.43M |